Curriculum
- 11 Sections
- 147 Lessons
- 16 Hours
Expand all sectionsCollapse all sections
- Module 1: Introduction to Epidemiology in Clinical Practice14
- 1.1Module Outline
- 1.21. Overview of Epidemiology and Its Relevance to Patient Care
- 1.31.1 What is Epidemiology and Clinical Epidemiology?
- 1.41.2 The Purpose of Clinical Epidemiology
- 1.51.3 Basic Principles of Epidemiology
- 1.62. Role of Epidemiological Methods in Improving Clinical Outcomes
- 1.72.1 Use of Epidemiological Findings to Guide Treatment Protocols and Public Health Policies
- 1.82.2 Evidence-Based Clinical Guidelines Derived from Epidemiological Research
- 1.92.3 Sensitivity, Specificity and Predictive Value in Diagnostic Tests
- 1.102.4 Role in Improving the Accuracy and Reliability of Clinical Diagnostics
- 1.112.5 Real-World Example: How Epidemiological Research Influenced Clinical Practice
- 1.123. Differentiating between clinical epidemiology and population epidemiology
- 1.133.1 Differences between clinical and population epidemiology
- 1.143.2 Interconnection Between Clinical and Population Epidemiology- How Population Epidemiology Informs Clinical Practice
- Module 2: Screening and Early Detection of Disease18
- 2.1Module Outline
- 2.21. Principles and Criteria for Effective Screening Programs
- 2.31.1 Definition of Screening Programs
- 2.41.2 Requirements for Instituting a Medical Screening Programme (Modern Criteria) and Revisiting the Wilson and Jungner Criteria
- 2.51.3 Types of Screening
- 2.61.4 Cost Effectiveness and Allocation in Screening
- 2.71.5 Over Diagnosis, Lead Time Bias, and Length Bias
- 2.81.6 Ethical Considerations in Screening
- 2.92. Use of Sensitivity, Specificity, Positive Predictive Value, and Negative Predictive Value in Evaluating Screening Tests
- 2.102.1 Biologic Variation of Human Population
- 2.112.2 Validity of Screening Tests
- 2.122.3 Measures of Validity in Screening Tests
- 2.132.4 Measures of Performance in Screening
- 2.142.5 Relationship Between Predictive Value and Disease Prevalence
- 2.152.6 Receiver Operating Characteristic (ROC) Curves and Area Under The Curve (AUC)
- 2.162.7 Trade-Offs Between Sensitivity and Specificity
- 2.172.8 Application of Bayes’ Theorem in Interpreting Screening Results
- 2.182.9 Case Studies of Successful Screening Initiatives
- Module 3: Application of Epidemiology in Clinical Practice13
- 3.1Module Outline
- 3.21. Application of Incidence & Prevalence in Clinical Settings
- 3.31.1 Introduction to Incidence & Prevalence in Public Health
- 3.41.2 Using Disease Data to Guide Screening & Prevention
- 3.52. The Role of Relative Risk, Odds Ratio, and Hazard Ratio for Clinical Decision-Making
- 3.62.1 Introduction to Risk Measures in Epidemiology
- 3.72.2 Understanding Relative Risk (Risk Ratio)
- 3.82.3 Understanding Odds Ratio (OR) – Concept & Interpretation
- 3.92.4 Understanding Hazard Ratio (HR) – Concept & Interpretation
- 3.103. Using Epidemiological Data to Assess Patient Prognosis & Treatment Options
- 3.113.1 Understanding Survival Analysis & Life Tables
- 3.123.2 How Survival Data Helps in Selecting the Best Treatment
- 3.133.3 How Bias Affects Survival Data & Clinical Decisions
- Module 4: Application of Study Designs in Patient Care13
- 4.1Module Outline
- 4.21. How Cohort, Case-Control, and Cross-Sectional Studies Inform Clinical Decisions
- 4.31.1. Features of Cohort Studies and Their Use in Risk-Factor Analysis
- 4.41.2. Case-Control Study Methodology – Selecting Controls and Analysing Odds
- 4.51.3. Cross-Sectional Studies for Prevalence Measurement and Healthcare Surveys
- 4.62. The Impact of Randomised Controlled Trials (RCTs) on Treatment Protocols
- 4.72.1. Designing and Conducting RCTs
- 4.82.2. Real-World Examples of RCTs Influencing Practice
- 4.92.3. Ethical Considerations in Conducting RCTs
- 4.103. Understanding Observational Studies and Their Relevance to Real-World Patient Care
- 4.113.1. Role of Observational Studies in Understanding Long-Term Outcomes
- 4.123.2. Common Biases and Their Mitigation
- 4.133.3. Examples of Observational Studies Leading to Policy Changes
- Module 5: Evidence-Based Medicine in Clinical Practice1
- Module 6: Surveillance Systems and Clinical Decision Making20
- 6.1Module Outline
- 6.21. Role of Disease Surveillance in Guiding Clinical Practice
- 6.31.1 Definition and Scope of Disease Surveillance
- 6.41.2 Importance of Early Detection and Response to Emerging Health Threats
- 6.51.3 Types of Surveillance
- 6.61.4 Integration of Surveillance Data in Clinical Workflow
- 6.71.5 Limitations and Challenges in Using Surveillance Data in Clinical Practice
- 6.82. Using Epidemiological Data from National & Global Health Surveillance Systems
- 6.92.1 Overview of Major Health Surveillance Systems
- 6.102.2 How Surveillance Data Informs Policies & Clinical Guidelines
- 6.112.3 Methods for Accessing & Interpreting Surveillance Reports
- 6.122.4 Role of Epidemiological Dashboards
- 6.132.5 Examples of Data-Driven Response
- 6.142.6 Global Challenges and Examples
- 6.153. Real-Time Application of Epidemiological Surveillance in Patient Care
- 6.163.1 Real-Time Disease Tracking Tools
- 6.173.2 Surveillance Informing Clinical Practice
- 6.183.3 Application of Predictive Analytics and Artificial Intelligence
- 6.193.4 Challenges of Using Real-Time Surveillance
- 6.203.5 Collaboration Between Public and Healthcare Systems for Rapid Response
- Module 7: Introduction to Epidemiology in Clinical Practice13
- 7.1Module Outline
- 7.21. Role of Epidemiology in Controlling Infectious Disease Outbreaks
- 7.31.1 Basics of Transmission Dynamics (Agent, Host, Environment)
- 7.41.2 Phases of Infectiousness: Incubation, Latent, Communicable, and Generation Time
- 7.51.3 Application in Outbreak Control (e.g., Cholera, Dengue, COVID-19)
- 7.62. Application of Epidemiological Models in Clinical Settings
- 7.72.1 R0: Impact on Outbreak Control and Clinical Workflows (e.g., Quarantine Duration)
- 7.82.2 Herd Immunity: Vaccine Coverage Thresholds (e.g., Measles, Polio)
- 7.92.3 Limitations of Models in Real-World Patient Care Settings
- 7.103. Case Management and Contact Tracing Strategies in Infectious Diseases
- 7.113.1 Isolation and Treatment Protocols for Infectious Diseases (e.g., TB, COVID-19)
- 7.123.2 Contact Tracing Principles: Incubation Periods, Communicability, and Prioritization
- 7.133.3 Challenges in High-Density Settings Like Hospitals and Slums
- Module 8: Epidemiology and Chronic Disease Management16
- 8.1Module Outline
- 8.21. Use of Epidemiological Data in Managing Chronic Conditions
- 8.31.1. Advanced Data Analytics in Chronic Disease Management
- 8.41.2 Geospatial Analysis for Chronic Disease Surveillance (Mapping disease hotspots to allocate healthcare resources)
- 8.51.3 Integration of Electronic Health Records (EHR) in Epidemiological Studies (Leveraging EHR data for real-time disease monitoring)
- 8.61.4 Assessing the impact of socioeconomic factors on disease prevalence
- 8.71.5 Policy and Legal Frameworks for Data Sharing in Chronic Disease Management
- 8.82. Long-term Follow-up and Surveillance in Chronic Disease Care
- 8.92.1 Strategies to Improve Patient Adherence and Engagement in Long-term Follow-up
- 8.102.2 Implementing telehealth and mobile health (mHealth) solutions in chronic diseases surveillance
- 8.112.3 Data Integration and Analysis for Long-term Surveillance
- 8.123. Impact of lifestyle interventions based on epidemiological research
- 8.133.1 Evidence based lifestyle modification programs
- 8.143.2 Epidemiological Studies Supporting the Effectiveness of Lifestyle Changes in Reducing Risk Factors
- 8.153.3 Long-term impacts of lifestyle interventions: Data from longitudinal studies showing benefits in managing chronic diseases
- 8.163.4 Insights from Epidemiological Research on Effective Behavioral Interventions
- Module 9: Health Outcomes and Patient-Centred Care1
- Module 10: Epidemiology in Public Health37
- 10.1Module Outline
- 10.21. Role of Epidemiology in Public Health Policy & Program Planning
- 10.31.1. Data Collection and Analysis for Policy Development
- 10.41.2. Role of Epidemiology in Setting Health Priorities
- 10.51.3. Evidence-Based Public Health Planning
- 10.61.4. Evaluating the Impact of Public Health Policies
- 10.71.5. Case Studies: Tobacco Control, Vaccination Policies
- 10.82. Epidemiology of Emerging & Re-emerging Diseases
- 10.92.1. Factors Driving the Emergence and Re-Emergence of Diseases
- 10.102.2. Global Health Surveillance Systems
- 10.112.3. Examples: Zika Virus, Ebola, Antimicrobial Resistance, COVID-19, SARS, MERS, HMPV
- 10.122.4. Role of One Health Approach
- 10.132.5. Strategies for Prevention and Control
- 10.143. Travel-Related Epidemiology for Infectious Diseases & Global Health Risks
- 10.153.1. Epidemiology and Travel-Related Infections (eg: Malaria, Dengue, COVID-19)
- 10.163.2. Vaccination Requirements for Travelers
- 10.173.3. Role of International Health Regulations (IHR)
- 10.183.4. Disease Mapping and Risk Assessment for Travelers
- 10.193.5. Public Health Advisories and Travel Bans
- 10.204. Monitoring NCD Trends & Interventions
- 10.214.1. Epidemiology of Key NCDs (Diabetes, Cardiovascular Diseases, Cancers, etc.)
- 10.224.2. Surveillance Systems for NCDs
- 10.234.3. Evaluation of NCD Interventions (eg: Lifestyle Modifications, Medication Adherence)
- 10.244.4. Impact of Social Determinants on NCD Trends
- 10.254.5. Global Initiatives to Combat NCDs (WHO Global NCD Action Plan)
- 10.265. Environmental & Occupational Health Risks
- 10.275.1. Principles of Environmental Epidemiology
- 10.285.2. Epidemiologic Methods in Occupational Health
- 10.295.3. Health Impacts of Air and Water Pollution
- 10.305.4. Occupational Exposure to Chemicals and Carcinogens
- 10.315.5. Emerging Issues: Climate Change, Urbanization
- 10.326. Public Health Interventions & Emergency Responses
- 10.336.1. Epidemiologic Basis for Vaccination Programs
- 10.346.2. Tobacco Control: Epidemiology and Policy
- 10.356.3. Managing Infectious Disease Outbreaks
- 10.366.4. Risk Communication During Public Health Emergencies
- 10.376.5. Role of Epidemiology in Disaster Preparedness and Response
- Module 11: Ethical Considerations in Clinical Epidemiology1
2.4 Role in Improving the Accuracy and Reliability of Clinical Diagnostics
2.4.1 How Epidemiology Enhances Diagnostic Practices
Epidemiological research informs the development of more accurate and reliable diagnostic tools. By identifying the populations most at risk, understanding disease progression and testing various diagnostic methods, epidemiology can help improve diagnostic practices in clinical settings.
Example:
Epidemiological studies helped identify genetic markers associated with breast cancer, leading to the development of targeted genetic testing for individuals at high risk, improving early detection and patient outcomes.